7,514
Total Claims
$990K
Drug Cost
885
Beneficiaries
$1,118
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-27%
Cost per patient vs peers
$1,118 vs $1,524 avg
-8%
Brand preference vs peers
12.5% vs 13.7% avg
Brand vs Generic
88% generic
Brand: 942 claims · $821K
Generic: 6,572 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 473 | $427K |
| Rivaroxaban | 130 | $117K |
| Alirocumab | 50 | $44K |
| Ticagrelor | 83 | $43K |
| Evolocumab | 48 | $36K |
| Sacubitril/Valsartan | 28 | $32K |
| Atorvastatin Calcium | 835 | $15K |
| Ezetimibe | 191 | $11K |
| Metoprolol Succinate | 527 | $10K |
| Rosuvastatin Calcium | 225 | $10K |
| Ranolazine | 70 | $8,591 |
| Nebivolol Hcl | 56 | $7,267 |
| Pravastatin Sodium | 176 | $6,043 |
| Amlodipine Besylate | 557 | $5,956 |
| Losartan Potassium | 328 | $5,768 |
Prescribing Profile
61
Unique Drugs
$576K
Patient Profile
73
Avg Age
52%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About